F. Balivo

Progression of renal damage in glycogen storage disease type I is associated to hyperlipidemia: a multicenter prospective Italian study.

G. Andria, D. Melis, A. Burlina, 2015, The Journal of pediatrics.

Impaired Bone Metabolism in Glycogen Storage Disease Type 1 Is Associated with Poor Metabolic Control in Type 1a and with Granulocyte Colony-Stimulating Factor Therapy in Type 1b

G. Andria, D. Melis, C. Dionisi-Vici, 2013, Hormone Research in Paediatrics.

The growth hormone-insulin-like growth factor axis in glycogen storage disease type 1: evidence of different growth patterns and insulin-like growth factor levels in patients with glycogen storage disease type 1a and 1b.

A. Colao, G. Andria, D. Melis, 2010, The Journal of pediatrics.

Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation

G. Muscogiuri, P. Formisano, G. Andria, 2015, Orphanet Journal of Rare Diseases.

Vitamin E Improves Clinical Outcome of Patients Affected by Glycogen Storage Disease Type Ib.

G. Andria, P. Marcolongo, A. Benedetti, 2015, JIMD reports.

Myasthenia gravis in a patient affected by glycogen storage disease type Ib: A further manifestation of an increased risk for autoimmune disorders?

B. Capaldo, G. Riccardi, G. Andria, 2008, Journal of Inherited Metabolic Disease.

Type a Niemann-Pick Disease

R. Taurisano, M. Sibilio, F. Caranci, 2008 .